ResearchMoz

Cardiac Prosthetic Devices Market (Mechanical Heart Valves, Tissue Heart Valves, Transcatheter Heart Valves, Implantable Pacemaker and External Pacemaker) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research
Published Date » 2013-12-04
No. Of Pages » 80
Cardiac prosthetic devices increase the survival rate and improve the quality of life in most patients. These devices are used to replace damaged or diseased natural valves of the heart. The research report on cardiac prosthetic devices provides a detailed analysis of the global market and helps in understanding the driving forces for growth of these devices. The report also provides analysis of major segments such as heart valves (mechanical heart valves, tissue heart valves and transcatheter heart valves) and pacemakers (implantable pacemaker and external pacemaker). Market size estimates and forecasts for the period 2011 to 2019 have been given for each segment and its sub-segments, in terms of USD million, using 2012 as the base year for calculations.

The market has been segmented geographically into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). Market size and forecast has been provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the cardiac prosthetic devices market and future opportunities is provided in the report.

Competitive landscape for each of the product type is provided and the market players are profiled with attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of all the key players for 2012 are provided and recommendations to accentuate market shares and ensure sustainability are provided in this report. Key market players profiled are Abbott Laboratories, Boston Scientific, Medtronic, Inc., St. Jude Medical and others.

The global cardiac prosthetic devicesmarket is segmented into the following categories:

Cardiac Prosthetic Devices Market, by Segments

  • Heart Valves
  • Mechanical Heart Valves
  • Tissue Heart Valves
  • Stented Tissue Valve
  • Stentless Tissue Valve
  • Transcatheter Heart Valves
  • Pacemaker
  • Implantable Pacemaker
  • Single-Chamber Battery Pacemaker
  • Dual-Chamber Battery Pacemaker
  • Triple-Chamber Battery Pacemaker
  • External Pacemaker

Cardiac Prosthetic Devices Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)
Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research

Chapter 2 Executive Summary
2.1 Global Cardiac Prosthetic Devices Market, by Segments, 2012 (USD Million)

Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Rising Geriatric Population
3.2.2 Rising Prevalence of Disorders such as Hypertension, Diabetes and Obesity
3.2.3 Increasing Demand for Minimally-Invasive Procedures
3.3 Market Restraints
3.3.1 Implementation of Affordable Healthcare Act
3.3.2 Strict Approval Process from Government Bodies
3.4 Market Opportunities
3.4.1 Big Opportunities in Emerging Economies with High Unmet Needs
3.4.2 Huge Scope for Alliance with Organizations having Complementary Strength
3.5 Porter’s Five Forces Analysis for the Global Cardiac Prosthetic Devices Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis for the Global Cardiac Prosthetic Devices Market, by Geography
3.7 Market Share by Key Players of Global Cardiac Prosthetic Devices Market, 2012
3.7.1 Global Cardiac Prosthetic Devices Market Share, by Key Players, 2012 (%)

Chapter 4 Cardiac Prosthetic Devices Market, by Segments
4.1 Overview
4.1.1 Global Cardiac Prosthetic Devices Market, by Segments, 2011 – 2019 (USD Million)
4.2 Heart Valves
4.2.1 Global Heart Valves Market, by Types, 2011 – 2019 (USD Million)
4.2.2 Mechanical Heart Valves
4.2.2.1 Global Mechanical Heart Valves Market, 2011 – 2019 (USD Million)
4.2.3 Tissue Heart Valves
4.2.3.1 Global Tissue Heart Valves Market, by Types, 2011 – 2019 (USD Million)
4.2.3.2 Stented Tissue Valve
4.2.3.2.1 Global Stented Tissue Valve Market, 2011 – 2019 (USD Million)
4.2.3.1 Stentless Tissue Valve
4.2.3.1.1 Global Stentless Tissue Valve Market, 2011 – 2019 (USD Million)
4.2.4 Transcatheter Heart Valves
4.2.4.1 Global Transcatheter Heart Valve Market, 2011 – 2019 (USD Million)
4.3 Pacemaker
4.3.1 Global Pacemaker Market, by Types, 2011 – 2019 (USD Million)
4.3.2 Implantable Pacemaker
4.3.3 Global Implantable Pacemaker Market, by Types, 2011 – 2019 (USD Million)
4.3.3.1 Single-Chamber Battery Pacemaker
4.3.3.1.1 Global Single-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
4.3.3.2 Dual-Chamber Battery Pacemaker
4.3.3.2.1 Global Dual-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
4.3.3.3 Triple-Chamber Battery Pacemaker
4.3.3.3.1 Global Triple-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
4.3.4 External Pacemaker
4.3.4.1 Global External Pacemaker Market, 2011 – 2019 (USD Million)

Chapter 5 Cardiac Prosthetic Devices Market, by Geography
5.1 Overview
5.1.1 Global Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.2 Comparative Analysis: Cardiac Prosthetic Devices Market, by Geography, 2012 & 2019 (Value %)
5.3 North America
5.3.1 North America Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.4 Europe
5.4.1 Europe Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.5 Asia-Pacific
5.5.1 Asia-Pacific Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.6 Rest of the World (RoW)
5.6.1 RoW Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)

Chapter 6 Recommendations
6.1 Market Strategies for Success
6.2 Barriers to be Considered

Chapter 7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategies
7.1.5 Recent Developments
7.2 Abiomed, Inc.
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategies
7.2.5 Recent Developments
7.3 AtriCure, Inc.
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategies
7.3.5 Recent Developments
7.4 Boston Scientific Corporation
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategies
7.4.5 Recent Developments
7.5 Edward Lifesciences Corporation
7.5.1 Company overview
7.5.2 Financial overview
7.5.3 Product Portfolio
7.5.4 Business Strategies
7.5.5 Recent Developments
7.6 Medtronic, Inc.
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Product Portfolio
7.6.4 Business Strategies
7.6.5 Recent Developments
7.7 Siemens Healthcare
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Product Portfolio
7.7.4 Business Strategies
7.7.5 Recent Developments
7.8 Sorin Group
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Product Portfolio
7.8.4 Business Strategies
7.8.5 Recent Developments
7.9 St. Jude Medical, Inc.
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Product Portfolio
7.9.4 Business Strategies
7.9.5 Recent Developments

List of Tables


TABLE 1 Market Snapshot: Global Cardiac Prosthetic Devices Market (2012 & 2019)
TABLE 2 Global Cardiac Prosthetic Devices Market, by Segments, 2011 – 2019 (USD Million)
TABLE 3 Global Heart Valves Market, by Types, 2011 – 2019 (USD Million)
TABLE 4 Global Tissue Heart Valves Market, by Types, 2011 – 2019 (USD Million)
TABLE 5 Global Pacemaker Market, by Types, 2011 – 2019 (USD Million)
TABLE 6 Global Implantable Pacemaker Market, by Types, 2011 – 2019 (USD Million)
TABLE 7 Global Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 8 North America Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 9 Europe Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 10 Asia-Pacific Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 11 RoW Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)

List of Figures


FIG. 1 Cardiac Prosthetic Devices: Market Segmentation
FIG. 2 Global Cardiac Prosthetic Devices Market, by Segments, 2012 (USD Million)
FIG. 3 Porter’s Five Forces Analysis: Cardiac Prosthetic Devices Market
FIG. 4 Market Attractiveness Analysis: Global Cardiac Prosthetic Devices Market, by Geography
FIG. 5 Cardiac Prosthetic Devices: Market Share, by Key Players, 2012 (%)
FIG. 6 Global Mechanical Heart Valves Market, 2011 – 2019 (USD Million)
FIG. 7 Global Stented Tissue Valve Market, 2011 – 2019 (USD Million)
FIG. 8 Global Stentless Tissue Valve Market, 2011 – 2019 (USD Million)
FIG. 9 Global Transcatheter Heart Valve Market, 2011 – 2019 (USD Million)
FIG. 10 Global Single-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
FIG. 11 Global Dual-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
FIG. 12 Global Triple-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
FIG. 13 Global External Pacemaker Market, 2011 – 2019 (USD Million)
FIG. 14 Comparative Analysis: Cardiac Prosthetic Devices Market, by Geography, 2012 & 2019 (Value %)
FIG. 15 Abbott Laboratories, Annual Revenue: 2010 – 2012 (USD Billion)
FIG. 16 Abiomed, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 17 AtriCure, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 18 Boston Scientific Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 19 Edward Lifesciences Corporation, Net Sales: 2010 – 2012 (USD Billion)
FIG. 20 Medtronic, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 21 Siemens Healthcare, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 22 Sorin Group, Net Sales: 2010 – 2012 (USD Million)
FIG. 23 St. Jude Medical, Inc., Annual Revenue: 2010 – 2012 (USD Million)

Upcoming Reports:

Natural Antioxidants - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Natural antioxidants are mostly found in fresh food. They have the ability to remove harmful/toxic substances from body. They are chemically free radicals and stable in their own way and hence do not give away electrons. Antioxidants convert harmful toxins into harmless products which are excreted from body as waste products. They prevent the body from oxidation which produces free radicals and damages cells. Foods which are rich in natural antioxidants helps prevent cancer and also act as anti-aging agents. They also reduces risk of heart disease by significantly absorbing bad...
Neurostimulation Market - Advanced Technologies, Global Market and Industry Analysis, Size, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Driven by rising health awareness and continuous disruptive innovations made in the field of medical and biological technologies, the global market for neurostimulation is expected to reach a market size valued at USD 7.3 billion in year 2018. The market is expected to grow at a healthy CAGR of 8.2% from 2012 – 2018. It was estimated at USD 4.2 billion in 2011. Medical devices manufacturing companies and their technological affiliates or subsidiaries are continuously working on developing novel devices and technologies which can enhance the efficacy of existing...
Blood Disease Treatment Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Blood comprises of red blood cells, white blood cells, plasma and platelets. Sometimes, people might be affected with different types of blood disorders and blood cancers due to aging, infections, exposure to certain chemicals, smoking, genetic disorders and other factors. Hence, the category of blood disorders is wide and numerous types of diseases fall under it. There are three main types of cancer that affect blood namely leukemia which affects the bone marrow and is caused by abnormal production of white blood cells. Myeloma is a type of blood cancer that affects plasma cells whereas...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Scientists Identify Cure for Dengue
Apr 18, 2014  
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year.  Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...
Infrared Sensors can Soon Be Used to Develop Night-Vision Lenses - A New Discovery Confirms
Apr 8, 2014  
People who fear the dark may soon have a reason to rejoice – an infrared sensor that can eventually be used for mechanizing night-vision lenses has been developed. This effectively means that one can also see through dark with the help of these lenses.  This technology seems possible all due to graphene, a layer of tightly packed carbon atoms that has allowed the creation of...